Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF August 9, 2019 | Archived Issues

Meetings and Events


Grand Rounds


Upcoming CME Conferences


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue.

Submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

FDA Warns About Xeljanz XR

The U.S. Food and Drug Administration (FDA) has approved new warnings about an increased risk of blood clots and death with the 10-mg, twice-daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis. The warning follows a review of interim data from an ongoing safety trial of tofacitinib in patients with rheumatoid arthritis.

The FDA website has more information.